D. E. Shaw & Co., Inc. Novo Nordisk A S Put Options Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $8.67 Million - $10.6 Million	72,800 Added 560.0%	85,800 $10.2 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $7.86 Million - $10.5 Million	-77,000 Reduced 85.56%	13,000 $1.67 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $1.14 Million - $1.37 Million	13,000 Added 16.88%	90,000 $9.31 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $3.5 Million - $7.68 Million	38,500 Added 100.0%	77,000 $7 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $4.66 Million - $5.16 Million	29,900 Added 347.67%	38,500 $6.23 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $1.14 Million - $1.37 Million	8,600 New	8,600 $1.37 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.